XML 207 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock
Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Accumulated Other Comprehensive Income
Total New Residential Stockholders’ Equity
Noncontrolling Interests in Equity of Consolidated Subsidiaries
Common Stock
Common Stock
Common Stock
Common Stock
Additional Paid-in Capital
Common Stock
Retained Earnings (Accumulated Deficit)
Common Stock
Total New Residential Stockholders’ Equity
Preferred Stock
Preferred Stock
Preferred Stock
Preferred Stock
Retained Earnings (Accumulated Deficit)
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings (Accumulated Deficit)
Cumulative Effect, Period of Adoption, Adjustment
Total New Residential Stockholders’ Equity
Cumulative Effect, Period of Adoption, Adjustment
Noncontrolling Interests in Equity of Consolidated Subsidiaries
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Total New Residential Stockholders’ Equity
Cumulative Effect, Period of Adoption, Adjustment
Preferred Stock
Total New Residential Stockholders’ Equity
Equity, beginning balance (in shares) at Dec. 31, 2018   0 369,104,429                                      
Equity, beginning balance at Dec. 31, 2018 $ 6,088,295 $ 0 $ 3,692 $ 4,746,242 $ 830,713 $ 417,023 $ 5,997,670 $ 90,625                            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                            
2020 Warrants 0                                          
Dividends declared on common stock (415,475)       (415,475)   (415,475)                              
Capital distributions (25,001)             (25,001)                            
Issuance of stock (in shares)                   46,000,000                        
Issuance of stock                 $ 751,393 $ 460 $ 750,933   $ 751,393                  
Options exercise (in shares)     348,613                                      
Option exercise     $ 3 (3)                                    
Director share grants (in shares)     67,738                                      
Director share grants 1,055   $ 1 1,054     1,055                              
Comprehensive income (loss)                                            
Net (loss) income 130,892       113,651   113,651 17,241                            
Net unrealized gain (loss) on securities 359,515         359,515 359,515                              
Reclassification of net realized (gain) loss on securities into earnings (89,844)         (89,844) (89,844)                              
Total comprehensive income (loss) 400,563           383,322 17,241                            
Equity, ending balance (in shares) at Jun. 30, 2019   0 415,520,780                                      
Equity, ending balance at Jun. 30, 2019 6,800,830 $ 0 $ 4,156 5,498,226 528,889 686,694 6,717,965 82,865                            
Equity, beginning balance (in shares) at Dec. 31, 2018   0 369,104,429                                      
Equity, beginning balance at Dec. 31, 2018 $ 6,088,295 $ 0 $ 3,692 4,746,242 830,713 417,023 5,997,670 90,625                            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                            
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201613Member                                          
Equity, ending balance (in shares) at Dec. 31, 2019   17,510,000 415,520,780                                      
Equity, ending balance at Dec. 31, 2019 $ 7,236,260 $ 423,444 $ 4,156 5,498,226 549,733 682,151 7,157,710 78,550                 $ 30,453 $ 13,658 $ 13,658 $ 16,795    
Equity, beginning balance (in shares) at Mar. 31, 2019   0 415,429,677                                      
Equity, beginning balance at Mar. 31, 2019 6,912,209 $ 0 $ 4,155 5,497,838 768,592 551,696 6,822,281 89,928                            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                            
Dividends declared on common stock (207,760)       (207,760)   (207,760)                              
Capital distributions (13,986)             (13,986)                            
Issuance of stock                 (266)   (266)   (266)                  
Options exercise (in shares)     51,517                                      
Director share grants (in shares)     39,586                                      
Director share grants 655   $ 1 654     655                              
Comprehensive income (loss)                                            
Net (loss) income (25,020)       (31,943)   (31,943) 6,923                            
Net unrealized gain (loss) on securities 167,162         167,162 167,162                              
Reclassification of net realized (gain) loss on securities into earnings (32,164)         (32,164) (32,164)                              
Total comprehensive income (loss) 109,978           103,055 6,923                            
Equity, ending balance (in shares) at Jun. 30, 2019   0 415,520,780                                      
Equity, ending balance at Jun. 30, 2019 6,800,830 $ 0 $ 4,156 5,498,226 528,889 686,694 6,717,965 82,865                            
Equity, beginning balance (in shares) at Dec. 31, 2019   17,510,000 415,520,780                                      
Equity, beginning balance at Dec. 31, 2019 7,236,260 $ 423,444 $ 4,156 5,498,226 549,733 682,151 7,157,710 78,550                 $ 30,453 $ 13,658 13,658 16,795    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                            
2020 Warrants 53,462     53,462                             53,462      
Dividends declared on common stock                 (62,356)     $ (62,356)                 $ (62,356)  
Dividends declared on preferred stock                           $ (25,579)   $ (25,579)           $ (25,579)
Capital contributions 1,791                                     $ 1,791    
Capital distributions $ (22,933)             (22,933)                            
Issuance of stock (in shares)                   97,394         16,100,000              
Issuance of stock                 1,662 $ 1 1,661     $ 389,548 $ 389,548           $ 1,662 $ 389,548
Options exercise (in shares) 0                                          
Director share grants (in shares)     126,344                                      
Director share grants $ 1,211   $ 1 1,210                             1,211      
Comprehensive income (loss)                                            
Net (loss) income (1,563,126)       (1,585,604)     22,478                     (1,585,604)      
Net unrealized gain (loss) on securities 90,773         90,773                         90,773      
Reclassification of net realized (gain) loss on securities into earnings (742,194)         (742,194)                         $ (742,194)      
Total comprehensive income (loss) (2,214,547)           (2,237,025) 22,478                            
Equity, ending balance (in shares) at Jun. 30, 2020   33,610,000 415,744,518                                      
Equity, ending balance at Jun. 30, 2020 5,388,972 $ 812,992 $ 4,158 5,554,559 (1,110,148) 30,730 5,292,291 96,681                            
Equity, beginning balance (in shares) at Mar. 31, 2020   33,610,000 415,649,214                                      
Equity, beginning balance at Mar. 31, 2020 5,330,464 $ 812,992 $ 4,157 5,500,308 (1,059,706) 6,135 5,263,886 66,578                            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                            
2020 Warrants 53,462     53,462     53,462                              
Dividends declared on common stock (41,574)       (41,574)   (41,574)                              
Dividends declared on preferred stock (14,357)       (14,357)   (14,357)                              
Capital contributions 1,791             1,791                            
Capital distributions (10,328)             (10,328)                            
Issuance of stock                 $ 79   $ 79   $ 79                  
Director share grants (in shares)     95,304                                      
Director share grants 711   $ 1 710     711                              
Comprehensive income (loss)                                            
Net (loss) income 44,129       5,489   5,489 38,640                            
Net unrealized gain (loss) on securities 56,398         56,398 56,398                              
Reclassification of net realized (gain) loss on securities into earnings (31,803)         (31,803) (31,803)                              
Total comprehensive income (loss) 68,724           30,084 38,640                            
Equity, ending balance (in shares) at Jun. 30, 2020   33,610,000 415,744,518                                      
Equity, ending balance at Jun. 30, 2020 $ 5,388,972 $ 812,992 $ 4,158 $ 5,554,559 $ (1,110,148) $ 30,730 $ 5,292,291 $ 96,681